Loading...
Regen BioPharma, Inc.
RGBP•PNK
HealthcareBiotechnology
$0.04
$-0.02(-33.23%)
Regen BioPharma, Inc. (RGBP) Company Profile & Overview
Explore Regen BioPharma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Regen BioPharma, Inc. (RGBP) Company Profile & Overview
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
SectorHealthcare
IndustryBiotechnology
CEODr. David Raymond Koos DBA, Ph.D.
Contact Information
Company Facts
1 Employees
IPO DateOct 6, 2014
CountryUS
Actively Trading